Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…

Brian Roman Biography and Net Worth

Chief Legal Officer of Viatris

Brian Roman is the Chief Legal Officer of Viatris. He has been with Viatris and its legacy company, Mylan, since 2003.

Brian is a seasoned executive with more than 30 years of experience encompassing key legal and business activities supporting the company’s operations, portfolio and growth initiatives. He is currently responsible for oversight of Viatris’ global legal organization including securities, global contracts, labor and employment, global regulatory, business development, litigation and intellectual property, among other areas. He is also responsible for the compliance, security, information security and privacy functions at Viatris.

Brian was appointed Mylan’s Global General Counsel in 2017 following his service as the company’s Chief Administrative Officer, in which he oversaw the Human Relations, Compliance, Facilities, Security, Information Security and Privacy functions. He previously served as Senior Vice President and Chief Compliance Officer; Vice President and General Counsel, North America; and Litigation Counsel.

Prior to joining Mylan, he was a Partner at Doepken Keevican & Weiss and began his career as an Associate Attorney at K&L Gates.

Brian earned a Bachelor of Science degree in industrial and labor relations from Cornell University in Ithaca, New York, and a Juris Doctor degree from the University at Buffalo Law School in Buffalo, New York.

He is a member of the Heinz History Center board of trustees and the Neville House Associates board of directors, both non-profit organizations.

What is Brian Roman's net worth?: The estimated net worth of Brian Roman is at least $905,456.51 as of May 28th, 2024. Mr. Roman owns 67,723 shares of Viatris stock worth more than $905,457 as of November 23rd. This net worth estimate does not reflect any other assets that Mr. Roman may own. Learn More about Brian Roman's net worth.
How old is Brian Roman?: Mr. Roman is currently 53 years old. There are 4 older executives and no younger executives at Viatris. Learn More on Brian Roman's age.
How do I contact Brian Roman?: The corporate mailing address for Mr. Roman and other Viatris executives is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. Viatris can also be reached via phone at (724) 514-1800 and via email at [email protected]. Learn More on Brian Roman's contact information.
Has Brian Roman been buying or selling shares of Viatris?: Brian Roman has not been actively trading shares of Viatris in the last ninety days. Most recently, Brian Roman sold 89,419 shares of the business's stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $10.38, for a transaction totalling $928,169.22. Following the completion of the sale, the insider now directly owns 67,723 shares of the company's stock, valued at $702,964.74. Learn More on Brian Roman's trading history.
Who are Viatris' active insiders?: Viatris' insider roster includes Paul Campbell (CAO and Corporate Controller), W. Cornwell (Director), Robert Coury (Chairman), Michael Goettler (CEO), James Kilts (Director), JoElleng Lyons Dillon (Director), Rajiv Malik (Director), Brian Roman (Chief Legal Officer), Menassie Taddese (insider), and Pauline van der Meer Morh (Director). Learn More on Viatris' active insiders.
Are insiders buying or selling shares of Viatris?: During the last twelve months, insiders at the sold shares 16 times. They sold a total of 966,975 shares worth more than $11,251,719.06. The most recent insider tranaction occured on November, 11th when insider Paul Campbell sold 26,925 shares worth more than $346,794.00. Insiders at Viatris own 0.1% of the company. Learn More about insider trades at Viatris.
Information on this page was last updated on 11/11/2024.

Brian Roman Insider Trading History at Viatris

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/28/2024	Sell	89,419	$10.38	$928,169.22	67,723

Brian Roman Buying and Selling Activity at Viatris

Viatris Company Overview

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Today's Range

Now: $13.37

$13.13

$13.50

50 Day Range

MA: $11.93

$11.27

$13.37

2 Week Range

Now: $13.37

$9.08

$13.62

Volume

8,252,232 shs

Average Volume

8,609,644 shs

Market Capitalization

$15.96 billion

P/E Ratio

N/A

Dividend Yield

3.68%

Beta

0.93

I hate to say I told you so

From WealthPress | Ad

Follow this link right away.

Brian Roman Biography and Net Worth

What is Brian Roman's net worth?

How old is Brian Roman?

How do I contact Brian Roman?

Has Brian Roman been buying or selling shares of Viatris?

Who are Viatris' active insiders?

Are insiders buying or selling shares of Viatris?